<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03034499</url>
  </required_header>
  <id_info>
    <org_study_id>0631-16-RMB</org_study_id>
    <nct_id>NCT03034499</nct_id>
  </id_info>
  <brief_title>Single Versus Multi-port Robotic Assisted Sacrocolpopexy for Repair of Vaginal Apex Prolapse</brief_title>
  <official_title>Single Versus Multi-port Robotic Assisted Sacrocolpopexy for Repair of Vaginal Apex Prolapse</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective randomized controlled study intended to compare the efficacy of 2 methods of
      robotic assisted sacrocolpopexy for the repair of vaginal apex prolapse:

        1. Via single-port.

        2. Via multi-port.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One hundred female patients diagnosed with vaginal apex prolapse will be recruited to a
      prospective randomized controlled study intended to compare the efficacy of 2 methods of
      robotic assisted sacrocolpopexy:

        1. Via single-port.

        2. Via multi-port. The patients will be evaluated and randomized 2 weeks before the
           expected date of surgery during which eligibility will be examined.

      Patients` electronic files will be reviewed post operatively to acquire information regarding
      medical history, prolapse scores, surgical information, anesthesia information and surgical
      complications.

      Patients will have 3 week and 3 month post operative follow-up sessions to determine surgical
      success, late complications and patient satisfaction.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 20, 2017</start_date>
  <completion_date type="Anticipated">June 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of surgical time</measure>
    <time_frame>Up to four months (2 weeks before surgery until 3 months post-surgery).</time_frame>
    <description>Comparison of surgical time in single versus multi-port robotic assisted sacrocolpopexy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of surgical success</measure>
    <time_frame>Up to four months (2 weeks before surgery until 3 months post-surgery).</time_frame>
    <description>Comparison of surgical success in single versus multi-port robotic assisted sacrocolpopexy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of surgical complications</measure>
    <time_frame>Up to four months (2 weeks before surgery until 3 months post-surgery).</time_frame>
    <description>Comparison of surgical complications (including bleeding and post operative pain) in single versus multi-port robotic assisted sacrocolpopexy.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>Single-port sacrocolpopexy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with vaginal apex prolapse randomized to undergo repair by single-port sacrocolpopexy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multi-port sacrocolpopexy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with vaginal apex prolapse randomized to undergo repair by multi- port sacrocolpopexy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Single-port sacrocolpopexy</intervention_name>
    <description>Single-port sacrocolpopexy surgery for the repair of vaginal apex prolapse.</description>
    <arm_group_label>Single-port sacrocolpopexy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Multi-port sacrocolpopexy</intervention_name>
    <description>Multi-port sacrocolpopexy surgery for the repair of vaginal apex prolapse.</description>
    <arm_group_label>Multi-port sacrocolpopexy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female patients with vaginal apex prolapse that are eligible for repair by
             sacrocolpopexy.

        Exclusion Criteria:

          -  Patients after previous hysterectomy.

          -  Patients after previous surgical procedures for prolapse repair.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female patients.</gender_description>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roy Lauterbach, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roy Lauterbach, MD</last_name>
    <phone>0529432416</phone>
    <email>roylauter@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rambam health care campus</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roy Lauterbach, MD</last_name>
      <phone>0529432416</phone>
      <email>r_lauterbach@rambam.health.gov.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2017</study_first_submitted>
  <study_first_submitted_qc>January 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2017</study_first_posted>
  <last_update_submitted>April 14, 2018</last_update_submitted>
  <last_update_submitted_qc>April 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>ROY LAUTERBACH MD</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

